Physical methods for the detection of carcinogen-DNA adducts in humans

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 288, Issue 1, 1993, Pages 19-29

  Weston, Ainsley ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Atomic absorbance spectroscopy; Electrochemical conductance; Fluorescence spectroscopy; Gas chromatography mass spectrometry; Molecular dosimetry

Indexed keywords

CARCINOGEN;

ATOMIC ABSORPTION SPECTROMETRY; BIOLOGICAL MONITORING; DNA ADDUCT; DOSIMETRY; FLUORESCENCE SPECTROSCOPY; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL; REVIEW; TECHNIQUE;

CARCINOGENS; CHROMATOGRAPHY, GAS; CONDUCTOMETRY; DNA; DNA DAMAGE; DNA MUTATIONAL ANALYSIS; ENVIRONMENTAL MONITORING; HUMAN; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ATOMIC ABSORPTION; SPECTRUM ANALYSIS, MASS;

EID: 0027164324     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/0027-5107(93)90204-S     Document Type: Article

References (72)

1. Endogenous oxidative DNA damage, aging, and cancer
2. Detection and structural characterization of amino polyaromatic hydrocarbon-deoxynucleoside adducts using fast atom bombardment and tandem mass spectrometry
3. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers
4. Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco
5. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G----T and A----C substitutions
6. Electroanalysis (Systematic Treatment), Introduction
7. Mutagenic specificity of alkylated and oxidized DNA bases as determined by site-specific mutagenesis
8. Analytical approaches for the determination of protein-carcinogen adducts using mass spectrometry
9. Monitoring human exposure to ethylene oxide by the determination of haemoglobin adducts using gas chromatography-mass spectrometry
10. DNA and protein adducts as indicators of in vivo methylation by nitrosatable drugs
11. Biomonitoring of human exposure to alkylating agents by measurement of adducts to haemoglobin or DNA
12. Influence of the degree of DNA modification on the immunochemical determination of cisplatin-DNA adduct levels
13. Hydroxyl free radical adduct of deoxyguanosine: sensitive detection and mechanisms of formation
14. Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers
15. An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3, 4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid
16. Molecular dosimetry of human aflatoxin exposures
17. Monitoring of oxidative free radical damage in vivo: analytical aspects
18. Detection of benzo[α]pyrene diol epoxide-DNA adducts in peripheral blood lymphocytes and antibodies to the adducts in serum from coke oven workers
19. Measurement of aflatoxin B1, its metabolites, and DNA adducts by synchronous fluorescence spectrophotometry
20. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke
21. Methylated purines in human liver DNA after probable dimethylnitrosamine poisoning
22. Fluorescence line narrowing: a high-resolution window on DNA and protein damage from chemical carcinogens
23. Fluorescence line narrowing: a high-resolution window on DNA and protein damage from chemical carcinogens
24. Laser spectroscopic studies of DNA adduct structure types from enantiomeric diol epoxides of benzo[a]pyrene
25. c-Haras containing 8-hydroxyguanine at codon 12 induces point mutations at the modified and adjacent positions
26. Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair
27. The identificaiton of a carcinogenic compound in coal-tar
28. Cigarette smoking induces formation of 8-hydroxydeoxyguanosine, one of the oxidative DNA damages in human peripheral leukocytes
29. Comparative laser spectroscopic study of DNA and polynucleotide adducts from the (+)-anti-diol epoxide of benzo[a]pyrene
30. Detection of benzo[a]pyrene diol epoxide-DNA adducts in human placenta
31. 32P-postlabeling analysis of human placental DNA known to contain benzo[a]pyrene diol epoxide adducts
32. Determinants of polycyclic aromatic hydrocarbon-DNA adducts in human placenta
33. Characterization of cisplatin adducts of oligonucleotides by fast atom bombardment mass spectrometry
34. Fluorescence spectrum of 12 benzpyrene
35. Site-specific mutagenesis using a gapped duplex vector: a study of translesion synthesis past 8-oxodeoxyguanosine in E. coli
36. Application of the 32P-postlabelling technique to detect DNA-adducts by cisplatin and methylating agents
37. Assay of excised oxidative DNA lesions: isolation of 8-oxoguanine and its nucleoside derivatives from biological fluids with a monoclonal antibody column
38. 7-Methylguanine adducts in DNA are normally present at high levels and increase on aging: analysis by HPLC with electrochemical detection
39. Platinum-DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry
40. Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation
41. Fifty years of benzo[a]pyrene
42. Development of immunoassays for the detection of carcinogen-DNA adducts
43. Platinum Drug-DNA interactions in human tissues measured by cisplatin-DNA enzyme-linked immunosorbent assay and atomic absorbance spectroscopy
44. DNA adducts induced by platinum drug chemo-therapeutic agents in human tissues
45. 32P-postlabeling assay for carcinogen-DNA adducts: nuclease PI-mediated enhancement of its sensitivity and applications
46. Quantitation of platinum-DNA binding after therapeutic levels of drug exposure, a novel use of graphite furnace spectrometry
47. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
48. Monoclonal antibodies to DNA modified by a benzo[a]pyrene diol epoxide
49. Urinary-8-hydroxy-2′-deoxyguanosine as a biological marker of in vivo oxidative DNA damage
50. [Trace analysis of biological substances by high-performance liquid chromatography with electrochemical detection]
51. Nucleic acid-carcinogen adducts in human dosimetry
52. Urinary markers for measuring exposure to endogenous and exogenous alkylating agents and precursors
53. Analysis of methylated and oxidized purines in urine by capillary gas chromatography-mass spectrometry
54. Introduction
55. Selected applications of electrochemical detectors in flowing liquids
56. Laser-induced fluorescence-line narrowing in ruby
57. Analysis of 8-hydroxydeoxyguanosine-DNA adducts in humans following exposure to oxidants; an interlaboratory study
58. Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA
59. An applied synchronous fluorescence spectrophotometric assay to study benzo[a]pyrene-diolepoxide-DNA adducts
60. Synchronous luminescence spectroscopy methodology and applicability
61. Evaluation of the fiber-optic antibody-based fluoroimmunosensor for DNA adducts in human placenta samples
62. Endogenous oxidative damage of deoxycytidine in DNA
63. Introduction to Mass Spectrometry and Gas Chromatography
64. Types of mass spectrometers
65. Fluorescence detection of benzo[a]pyrene-DNA adducts in human lung
66. Measurement of carcinogen-macromolecular adducts and serum antibodies recognizing DNA adducts in biological specimens from people exposed to chemical carcinogens
67. Development of preparative immunoaffinity chromatography for the isolation of aromatic amine-DNA adducts from humans
68. Derivative fluorescence spectral analysis of polycyclic aromatic hydrocarbon-DNA adducts in human placenta
69. Fluorescence and mass spectral evidence for the formation of benzo[a]pyrene anti-diol-epoxide-DNA and -hemoglobin adducts in humans
70. Fluorescence detection of lesions in DNA
71. Detection of DNA damage in studies on cancer etiology and prevention
72. Chemical carcinogenesis: from animal models to molecular models in one decade